arrow
S

Steffen Boettcher

broad institute
H指数:27
被引数:4,857

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Functional Classification of Monoallelic TP53 Mutations Refines Prognostic Stratification in Myelodysplastic Neoplasms

单等位基因TP53突变的功能分类细化了骨髓增生异常性肿瘤的预后分层

Blood
IF23.1
2026-10-060
OAAI
SLIT2 modulates leukaemic cell proliferation and stromal support in acute myeloid leukaemia models

SLIT2调节急性髓系白血病模型中白血病细胞的增殖和基质支持

2026-09-290
PRE
Chemoresistance of TP53 mutant acute myeloid leukemia requires the mevalonate byproduct, geranylgeranyl pyrophosphate, for induction of an adaptive stress response

TP53突变型急性髓系白血病的化疗耐药性需要甲羟戊酸代谢产物法尼基焦磷酸,以诱导适应性应激反应。

Leukemia
IF13.4
2025-07-090
OAAI
Restoring p53-wild type conformation in TP53-Y220C mutant acute myeloid leukemia

在TP53-Y220C突变的急性髓系白血病中恢复p53野生型构象

Blood
IF23.1
2025-07-050
PRE
Targeting of epigenetic co-dependencies enhances anti-AML efficacy of Menin inhibitor in AML with MLL1-r or mutant NPM1 (vol 13, 53, 2023)

靶向表观遗传共依赖性增强了在MLL1-r或突变NPM1的AML中Menin抑制剂的抗AML疗效(卷13,53,2023)

2025-05-210
OA
Endothelial CCR2 Signaling Induced by Colon Carcinoma Cells Enables Extravasation via the JAK2-Stat5 and p38MAPK Pathway (vol 22, pg 91, 2012)

由结肠癌细胞诱导的内皮CCR2信号通过JAK2-Stat5和p38MAPK通路促进外渗 (vol 22, pg 91, 2012)

2025-05-010
PRE
Mutagenic DNA Lesions in Normal Hematopoietic Stem Cells Persist for Years Causing Distinct Patterns of Mutation

正常造血干细胞中的致突变DNA损伤持续数年并导致特异的突变模式

BLOOD
IF23.1
2024-11-050
PRE
Clonal dynamics after allogeneic haematopoietic cell transplantation

同种异基因造血细胞移植后的克隆动态

Nature
IF48.5
2024-10-300
OAAI
Targeting the mevalonate or Wnt pathways to overcome CAR T-cell resistance in TP53-mutant AML cells

靶向甲羟戊酸或Wnt途径以克服TP53-mutant AML细胞中的CAR T细胞抗性

2024-02-143
OAAI
Enhanced TP53 reactivation disrupts MYC transcriptional program and overcomes venetoclax resistance in acute myeloid leukemias
2023-12-013
OAAI
Circulating senescent myeloid cells infiltrate the brain and cause neurodegeneration in histiocytic disorders
IMMUNITY
IF26.3
2023-12-0111
OAAI
RUNX1 mutations mitigate quiescence to promote transformation of hematopoietic progenitors in Fanconi anemia
LEUKEMIA
IF13.4
2023-06-302
PRE